Compare Amylx Pharmaceuticals Inc (AMLX) vs S&P500 ETF (SPY) Price & Performance

Amylx Pharmaceuticals IncTrade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs S&P500 ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while S&P500 ETF trades at $772.45. Which is the better fit depends on your goals.

	AMLX	SPY
Market Cap	$2.64B	—
Sector	Health	—
52-Week High	$24.19	$773.22
52-Week Low	$7.82	$631.99
Enterprise Value	$2.39B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMLX

View details →

SPY

SPYI ETF offers high tax-free yield but with high fees and capped upside in Roth IRAs.24/7 Wall Street · 18 hours agoBearish Hyperscalers ramp up AI spending betting on AGI, but risks and doubts remain high.Seeking Alpha · 1 day agoNeutral Vanguard High Dividend Yield ETF lags S&P 500 by $141K over 10 years despite dividends.24/7 Wall Street · 1 day agoBearish View details →

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.